NRX Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$2.08(as of Mar 16, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

NRX Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.08
Ticker SymbolNRXP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
EmployeesUnknown
CountyUSA
Market Cap$59.3M
EBIDTA-15.2M
10-Day Moving Average1.83
P/E Ratio-1.21
20-Day Moving Average1.83
Forward P/E Ratio1.51
50-Day Moving Average2.01
Earnings per Share-2.31
200-Day Moving Average2.63
Profit Margin-2,433.88%
RSI59.89
Shares Outstanding31.9M
ATR0.13
52-Week High3.84
Volume2,060,956
52-Week Low1.58
Most Recent Support Level1.62
Book Value-25.8M
Most Recent Resistance Level1.89
P/B Ratio-1.80
Upper Keltner2.13
P/S Ratio184.96
Lower Keltner1.53
Debt-to-Equity Ratio2.13
Next Earnings DateUnknown
Cash Surplus-33.4M
Next Ex-Dividend DateUnknown

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital; and has as a partnership with neurocare Group AG to create a nationwide network of clinics to offer integrated neuroplastic care for the treatment of Depression, PTSD, and other serious mental health disorders. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.

NRX Pharmaceuticals Inc In Our Stock Scanner

As of Mar 17, 2026
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.